Analysis of Revenues
Paying user area
Try for free
Abiomed Inc. pages available for free this week:
- Income Statement
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Income Statement
- Analysis of Profitability Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Return on Equity (ROE) since 2005
- Total Asset Turnover since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abiomed Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Revenues as Reported
Abiomed Inc., income statement, revenues
US$ in thousands
| 12 months ended: | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product revenue | |||||||||||||
| Service and other revenue | |||||||||||||
| Revenue |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
- Revenue Growth
- The total revenue exhibited a consistent upward trend across the analyzed period, increasing from $445.3 million in 2017 to $1.031 billion in 2022. This represents more than a twofold increase over the six-year span, indicating strong overall business growth.
- Product Revenue
- Product revenue showed a steady and substantial increase from $423.7 million in 2017 to $984.5 million in 2022. Notably, there was a marked acceleration in growth between 2017 and 2019 and a slight plateau from 2019 to 2021, with revenues nearly flat around the $806 million mark. However, 2022 saw a significant rebound, reaching the highest value in the period.
- Service and Other Revenue
- This segment grew consistently but at a much slower pace compared to product revenue. Starting at $21.6 million in 2017, it rose to $47.2 million by 2022. The growth is steady with no notable fluctuations, roughly doubling over the six-year period, contributing a small but growing portion to the total revenue.
- Proportional Contribution
- Product revenue dominates total revenue, contributing over 90% throughout the entire period. Although service and other revenue increased, its share of total revenue remains relatively minor, reflecting the primary reliance on product sales for revenue generation.
- Summary of Trends
- The company experienced solid revenue expansion driven predominantly by its product sales, with service revenues providing incremental support. The plateau between 2019 and 2021 in product revenue could suggest market saturation, operational constraints, or other external factors, followed by a strong resurgence in 2022. Overall, the financial data indicate robust growth and a healthy revenue structure with diversified though product-centric revenue streams.